MSF Khayelitsha, Cape Town, South Africa.
J Int AIDS Soc. 2013 Jul 4;16(1):18518. doi: 10.7448/IAS.16.1.18518.
Despite the rapid expansion of antiretroviral therapy (ART) programmes in developing countries, pre-treatment losses from care remain a challenge to improving access to treatment. Youth and adolescents have been identified as a particularly vulnerable group, at greater risk of loss from both pre-ART and ART care. Point-of-care (POC) CD4 testing has shown promising results in improving linkage to ART care. In Khayelitsha township, South Africa, POC CD4 testing was implemented at a clinic designated for youth aged 12-25 years. We assessed whether there was an associated reduction in attrition between HIV testing, assessment for eligibility and ART initiation.
A before-and-after observational study was conducted using routinely collected data. These were collected on patients from May 2010 to April 2011 (Group A) when baseline CD4 count testing was performed in a laboratory and results were returned to the clinic within two weeks. Same-day POC CD4 testing was implemented in June 2011, and data were collected on patients from August 2011 to July 2012 (Group B).
A total of 272 and 304 youth tested HIV-positive in Group A and Group B, respectively. Group B patients were twice as likely to have their ART eligibility assessed compared to Group A patients: 275 (90%) vs. 183 (67%) [relative risk (RR)=2.4, 95% CI: 1.8-3.4, p<0.0001]. More patients in World Health Organization (WHO) Stage 1 disease (85% vs. 69%), with CD4 counts≥350 cells/µL (58% vs. 35%) and more males (13% vs. 7%) were detected in Group B. The proportion of eligible patients who initiated ART was 50% and 44% (p=0.6) in Groups B and A, respectively; and 50% and 43% (p=0.5) when restricted to patients with baseline CD4 count≤250 cells/µL. Time between HIV-testing and ART initiation was reduced from 36 to 28 days (p=0.6).
POC CD4 testing significantly improved assessment for ART eligibility. The improvement in the proportion initiating ART and the reduction in time to initiation was not significant due to sample size limitations.
POC CD4 testing reduced attrition between HIV-testing and assessment of ART eligibility. Strategies to improve uptake of ART are needed, possibly by improving patient support for HIV-positive youth immediately after diagnosis.
尽管发展中国家的抗逆转录病毒疗法(ART)项目迅速扩大,但治疗前的损失仍然是改善治疗机会的一个挑战。青年和青少年已被确定为一个特别脆弱的群体,他们在接受 ART 治疗之前和治疗期间都面临更大的损失风险。即时检测(POC)CD4 检测在改善与 ART 护理的联系方面显示出了有希望的结果。在南非的 Khayelitsha 镇,POC CD4 检测在一个专为 12-25 岁青少年设计的诊所中实施。我们评估了 HIV 检测、ART 资格评估和启动之间是否存在相关的损耗减少。
使用常规收集的数据进行了一项前后观察研究。这些数据是在 2010 年 5 月至 2011 年 4 月(A 组)期间收集的,当时在实验室进行了基线 CD4 计数检测,结果在两周内返回诊所。2011 年 6 月实施了当天的 POC CD4 检测,并在 2011 年 8 月至 2012 年 7 月期间(B 组)收集了患者的数据。
A 组和 B 组分别有 272 名和 304 名青年 HIV 检测呈阳性。与 A 组相比,B 组患者接受 ART 资格评估的可能性是 A 组的两倍:275 名(90%)与 183 名(67%)[相对风险(RR)=2.4,95%CI:1.8-3.4,p<0.0001]。B 组中更多的患者处于世界卫生组织(WHO)疾病阶段 1(85%比 69%),CD4 计数≥350 个细胞/µL(58%比 35%)和更多的男性(13%比 7%)。B 组和 A 组中分别有 50%和 44%(p=0.6)的合格患者开始接受 ART,而在将基线 CD4 计数≤250 个细胞/µL 的患者限制为合格患者时,分别有 50%和 43%(p=0.5)开始接受 ART。从 HIV 检测到开始 ART 的时间从 36 天缩短到 28 天(p=0.6)。
POC CD4 检测显著改善了 ART 资格评估。由于样本量限制,开始接受 ART 的比例的提高和开始接受 ART 的时间的缩短并不显著。
POC CD4 检测减少了 HIV 检测和评估 ART 资格之间的损耗。需要采取提高接受 ART 治疗的策略,可能需要通过在诊断后立即为 HIV 阳性青年提供更好的患者支持来实现。